Total Funding
71
56
Total FundingSeed raised
Growth Score
-6 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
182570
EIR Pharmaceuticals focuses on developing and commercializing health, wellness and pharmaceutical products for humans and animals.
John Crowe: Co-Founder & Chief Executive Officer
About the Company
EIR Pharmaceuticals is a biotechnology company that focuses on developing and commercializing health, wellness and pharmaceutical products for humans and animals.
Its unique approach uses an intense science-based vetting system and a business-minded, scientific philosophy in pursuing products that are both commercially viable and provide a
significant health benefit. The company's team has a strong history in drug discovery, drug development, regulatory affairs, and commercialization, making us well-suited to take products from concept to the marketplace.
